How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NL

NASDAQ:NLSP
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NL

NLS Pharmaceutics AGNASDAQ NLSP Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is NLSP undervalued compared to its fair value?

The fair value of NLSP stock is hidden USD. Relative to the market price of 0.18 USD NLS Pharmaceutics AG is hidden.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headq...[More about valuation]

NLS Pharmaceutics AG Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.01 $B

Price:

0.18 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.199

FINANCIALS

NLS Pharmaceutics AG financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0075 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0076 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.0023 B
-0.0043 B

Financial Position Analysis

Assets

0.0023 B
Current Assets
0.0022 B
Total non-current assets
0 B

Total current liabilities
0.0039 B
Total non-current liabilities
0.0027 B

Cash Flow Statement

-0.0073 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0073 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

NLS Pharmaceutics AG fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is NLSP attractive for investment based on fundamental analysis?

NLSP stock rating is hidden. NLS Pharmaceutics AG is a hidden by Eyestock methodology.

Get NLSP Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

NLSP analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for NLSP to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

NLS Pharmaceutics AG competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

NLS Pharmaceutics AG dividends

NLSP dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About NLSP stock

About the company NLS Pharmaceutics AG

Market cap $B

0.01

Dividend yield

Shares outstanding

27.4536 B

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 6 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.

NLSP profile

  • Ticker

    NLSP

  • Country

    Switzerland

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    29 January 2021

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    6

  • City

    Zurich

  • Address

    The Circle 6

  • Cusip

    H57830103